ArticleNPJ precision oncology2024

Efficacy of PARP inhibitor therapy after targeted BRAF/MEK failure in advanced melanoma.

Jordan Phillipps et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.